The clinical significance of ABCB5 has been extensively documented, showing strong correlations between its expression and poorer patient outcomes, such as increased tumor progression and reduced overall survival in colorectal and oral squamous cell carcinomas. This evidence concerns the gene ABCB5 and oral cavity squamous cell carcinoma.